There are two ways in which you can have a BRCA1 or BRCA2 mutation. The first is germline, which means it was probably inherited from one parent, is present in all of your body cells, and can be passed on with 50% probability to the offspring, hence the need for genetic counselling. The second is somatic, which means that the mutation arose in the tumour itself, is not in the rest of the body, and cannot be passed to offspring. As LynEyre says, testing is not done routinely, and these mutations only affect a minority of patients. However, patients with one of these mutations (or in other related genes such as ATM) are responsive to a type of drug called a PARP inhibitor (example, olaparib) and there are several current clinical trials testing these in PC patients. To get on such a trial, one would be DNA tested, both a blood test for the germline mutation and by using a biopsy sample for the somatic ones. I've had this done myself and I'm on a trial at the moment.
As for survival, the jury seems to be out; I've seen at least one publication that says outcomes are similar with or without the mutation.
Good luck with everything!